Insider Transactions in Q2 2022 at Nuvalent, Inc. (NUVL)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2022
|
Christopher Durant Turner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,513
+50.0%
|
$87,078
$6.89 P/Share
|